Abstract:High content antibody microarrays are powerful tools to evaluate alterations in the levels and post‐translational status of hundreds of proteins of interest with only microgram amounts of crude cell and tissue lysate protein. However, interpretations of the results from traditional antibody microarray approaches have been hampered by the problems associated with sample preparation and protein detection, even when potent and specific antibodies are printed on these arrays. The Kinex™ KAM‐900P and KAM‐1150E antibody microarrays permitted semi‐quantitative measurements of the expressions, post‐translational modifications, and interactions of proteins with as little as 25 μg of lysate proteins. When used in combination, these microarrays utilize approximately 1250 different pan‐specific and 600 phosphosite‐specific antibodies for tracking protein kinases, phosphatases and other low abundance regulatory proteins involved in cell growth, stress responses and apoptosis. With diverse detection protocols, these microarrays enable high density profiling of lysate protein levels, phosphorylation and ubiquitination, and protein‐protein interactions in diverse experimental model systems, including human tumour cells in response to epidermal growth factor (EGF) and insulin treatment. One method involved the capture of in vitro biotin‐labeled lysate proteins, followed by their detection with dye‐labeled anti‐biotin antibody. False positive signals from associated proteins in complexes with the targets were reduced by chemical cleavage at cysteine residues with 2‐nitro‐5‐thiocyanatobenzoic acid (NTCB) prior to their capture on the array, and this also produced more uniformity of the dye signals for protein targets despite vast differences in their sizes. Transient changes in protein phosphorylation in EGF treated cells that were typically lost when processed by conventional methods were better preserved by chemical cleavage right at time of sample homogenization, and the chemically cleaved samples were stable for weeks without the need for refrigeration or freezing. Biotin‐labelling and subsequent detection of the antibody‐captured proteins on the arrays with a dye‐labeled anti‐biotin antibody reduced non‐specific background signals, allowed for a greater dynamic range of detection of up to 10,000‐fold, and enhanced discrimination of subtle changes in protein expression or phosphorylation. In conjunction with other detection protocols, such as the usage of dye‐labeled reporter antibodies for generic protein‐tyrosine phosphorylation in sandwich antibody microarrays (SAM format) or generic protein phosphorylation with nanoparticles such as pAMIGO (PAM format), it is also feasible to monitor changes in general phosphorylation of low abundance cell signalling proteins. The SAM format can also be adapted to identify target proteins that are subjected to other types of covalent modification such as ubiquitination and how these are altered when appropriate dye‐labelled covalent modification‐specific antibodies are deployed to probe the KAM‐900P and KAM‐1150E antibody microarrays. Furthermore, the SAM format has been used to monitor the interactions of complexed scaffolding, adaptor and chaperone proteins with signalling proteins that are captured on the antibody microarrays with specific, dye‐labelled reporter antibodies for the interacting proteins. Support or Funding Information This research was funded by Kinexus Bioinformatics Corporation, and LY was supported by a studentship award from the National Sciences and Engineering Research Council of Canada. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Reverse Phase Protein Arrays

Solid Pin Protein Array Printing Platforms

A reverse phase protein array based phospho-antibody characterization approach and its applicability for clinical derived tissue specimens

Characterization of protein expression levels with label-free detected reverse phase protein arrays

High-Throughput Phosphorylation Screening and Validation Through Ti(IV)-Nanopolymer Functionalized Reverse Phase Phosphoprotein Array.

Discovery of Electrophiles and Profiling of Enzyme Cofactors.

Harnessing the potential of reverse‐phase protein array technology: Advancing precision oncology strategies

High-throughput profiling of histone post-translational modifications and chromatin modifying proteins by reverse phase protein array

Two-color, Rolling-Circle Amplification on Antibody Microarrays for Sensitive, Multiplexed Serum-Protein Measurements.

Phosphorylated Protein Chip Combined with Artificial Intelligence Tools for Precise Drug Screening

Reversed-phase-reversed-phase liquid chromatography approach with high orthogonality for multidimensional separation of phosphopeptides.

The effects of sample handling on proteomics assessed by reverse phase protein arrays (RPPA): Functional proteomic profiling in leukemia

Real-time SPR Phase Detection for Protein Micro-array

Tracking Protein Expression, Post‐translational Modifications and Interactions with High Content Antibody Microarrays

Picoliter Well Array Chip-Based Digital Recombinase Polymerase Amplification for Absolute Quantification of Nucleic Acids.

Critical insight into recombinase polymerase amplification technology

Peptide and Protein Assays Using Customizable Bio-Affinity Arrays Combined with Ambient Ionization Mass Spectrometry

Using Reciprocal Protein-Peptide Array Screening to Unravel Protein Interaction Networks.

Ratiometric Electrochemical Proximity Assay for Sensitive One-Step Protein Detection.

DNA detection using recombination proteins

Development and characterization of new tools for detecting poly(ADP-ribose) in vitro and in vivo